Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy-Reference-Cited by-同舟云学术

Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy

Published:2024-01 Issue:1 Volume:118 Page:137-141
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zaniletti Isabella,Gunn Heather J.,Hallemeier Christopher L.,Laughlin Brady Scott^ORCID,Leavitt Todd R.,Haddock Michael G.,Merrell Kenneth W.,Leenstra James L.,May Byron C.,Ashman Jonathan B.,DeWees Todd A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference11 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2024

2. Radiotherapy for pancreatic cancer;Yamada,2021

3. Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer;Cella;Qual Life Res,2013

4. Measuring health-related quality of life in patients with hepatobiliary cancers: The Functional Assessment Of Cancer Therapy–Hepatobiliary questionnaire;Heffman;J Clin Oncol,2002

5. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201;Loehrer;J Clin Oncol,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer;Technical Innovations & Patient Support in Radiation Oncology;2024-03